Biopharma’s Survival Moment
March 2, 2026
Why the next decade will be defined by operational reinvention, not just scientific breakthroughs
5 min read
False
March 2, 2026
Why the next decade will be defined by operational reinvention, not just scientific breakthroughs
5 min read
February 16, 2026
Part of a broader multibillion-dollar effort to expand R&D and manufacturing in the US
1 min read
By Achim Link
January 28, 2026
GLP-1 peptides validated the science. CMC will validate the small molecule modality for GLP-1 efficacy, scalability, and access.
4 min read
By Michelle Sestak
January 26, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
4 min read
January 21, 2026
Green issues shouldn’t be treated as “woke.” Instead, they should be seen as pharma’s license to operate. Three industry experts discuss.
10 min read
By Stephanie Vine
January 14, 2026
In short: Yes, says Mat Minardi, Chief Scientific Officer at Sterling Pharma Solutions
7 min read
By Stefan Lutz
January 6, 2026
Can enzyme-catalyzed processes address the limitations of traditional RNA synthesis and define the future of scalable, sustainable manufacturing of RNA therapeutics?
5 min read
By Stephanie Vine
December 3, 2025
“For those of you who are removed from direct interaction with the patients…please remember that your work really matters. It is making a huge difference to human lives.”
3 min read
December 1, 2025
What were the standout drug development and manufacturing technologies launched in 2025? Here’s our list based on your nominations.
8 min read
November 28, 2025
As industry conversations around manufacturing change, we caught up with Cytiva’s Joe Makowiecki to discuss modular and flexible solutions.
False
False
False